Neoadjuvant Immune Checkpoint Inhibitor Therapy in Melanoma: Efficacy, Safety and Timing
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-190X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neoadjuvant Immune Checkpoint Inhibitor Therapy in Melanoma: Efficacy, Safety and Timing ; volume:36 ; number:3 ; day:9 ; month:4 ; year:2022 ; pages:373-380 ; date:5.2022
BioDrugs ; 36, Heft 3 (9.4.2022), 373-380, 5.2022
- Urheber
-
Akkooi, Alexander C. J. van
Zijlker, Lisanne P.
Wouters, Michel W. J. M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40259-022-00525-x
- URN
-
urn:nbn:de:101:1-2022073008045892578496
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Akkooi, Alexander C. J. van
- Zijlker, Lisanne P.
- Wouters, Michel W. J. M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
Predictors of responses to immune checkpoint blockade in advanced melanoma
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation
Why does circadian timing of administration matter for immune checkpoint inhibitors’ efficacy?
Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
Predictors of responses to immune checkpoint blockade in advanced melanoma
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation
Why does circadian timing of administration matter for immune checkpoint inhibitors’ efficacy?
Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
Predictors of responses to immune checkpoint blockade in advanced melanoma
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation